Danaher Corporation stock reports 5.5 percent revenue growth for Q2 2026
Published on 10/05/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher Corporation stock (ISIN US2358511028) was last at USD 221.21 on the NYSE on October 5, 2026, up USD 7.15 or 3.34 percent from the previous close. The latest operating figures show second-quarter revenue of USD 6.26 billion, with quarterly EPS of USD 1.94 above consensus of USD 1.85.
Quarterly revenue beats expectations
According to MarketBeat, Danaher reported its second-quarter results on July 20, 2026, with EPS of USD 1.94 versus analyst expectations of USD 1.85. The USD 0.09 beat gives the earnings story a measurable edge, while revenue of USD 6.26 billion exceeded the USD 6.12 billion consensus estimate.
Revenue was up 5.5 percent year over year in the quarter, according to MarketBeat. For investors, the important distinction is that the reported growth is paired with an earnings beat rather than relying on revenue alone.
Analyst targets move above USD 250
RBC Capital raised its Danaher price target to USD 250 from USD 215 and maintained an Outperform rating on October 1, 2026, according to Investing.com. The new target lies 13.0 percent above the USD 221.21 price, based on the October 5 market level.
MarketBeat lists a Moderate Buy consensus, with two Strong Buy ratings, seventeen Buy ratings and five Hold ratings, alongside an average target of USD 234.09, according to MarketBeat. That average stands 5.8 percent above the October 5 price, a smaller gap than RBC's target implies.
Recovery meets a higher valuation
Danaher guided adjusted diluted 2026 EPS to USD 8.45 to USD 8.60, while full-year core revenue growth is expected at 3 percent to 4 percent, according to Yahoo Finance. The combination places execution of the recovery at the center of the stock story, especially as bioprocessing orders improve while diagnostics growth remains restrained.
October 21 sets the next checkpoint
Danaher is scheduled to report third-quarter results on October 21, 2026, according to Investing.com. Danaher Corporation stock had a 52-week range of USD 160.93 to USD 242.80 and a market capitalization of USD 155.5 billion as of October 5, 2026.
Danaher Corporation stock details
- Company: Danaher Corporation
- ISIN: US2358511028
- WKN: 866197
- Ticker: DHR
- Trading venue: NYSE
- Price (as of October 5, 2026, 4:01 p.m. ET): USD 221.21
- Market capitalization: USD 155.5 billion (as of October 5, 2026)
- 52-week range: USD 160.93-242.80 (as of October 5, 2026)
- Volume: 3,079,987 shares
- Sector / Industry: Healthcare industry / life sciences tools and diagnostics
Upcoming dates for Danaher Corporation stock
- October 21, 2026: Third-quarter earnings report
